United States · Health Care · USD · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average
Amounts in USD; stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Nu-Med Plus, Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| ROE | 23.1% | 19.2% | 15.31% | 13.35% | 12.03% | 11.73% |
|---|---|---|---|---|---|---|
| Sector average | 20.42% | 71.17% | 5.82% | 58.79% | 17.46% | 2.74% |
| ROA | -650.1% | -759.96% | -752.19% | -756.44% | -774.07% | -849.92% |
| Total Assets | $7,911.00 | $7,250.00 | $7,250.00 | $7,250.00 | $7,250.00 | $7,250.00 |
| Net Income | -$56,182.00 | -$57,608.54 | -$54,533.66 | -$54,842.07 | -$56,120.43 | -$61,619.26 |